Product Usage:
THIS PRODUCT IS INTENDED FOR RESEARCH PURPOSES ONLY.
All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.

ARA-290
14 mgARA-290 (Cibinetide) is a next-generation healing peptide derived from erythropoietin. It selectively activates the innate repair receptor to trigger powerful anti-inflammatory and tissue-protective responses — without any blood cell stimulation. Clinically studied in neuropathic pain and metabolic syndrome, ARA-290 represents a breakthrough in targeted tissue repair.
Purchase Option
ARA-290 (Cibinetide) is a next-generation healing peptide derived from erythropoietin. It selectively activates the innate repair receptor to trigger powerful anti-inflammatory and tissue-protective responses — without any blood cell stimulation. Clinically studied in neuropathic pain and metabolic syndrome, ARA-290 represents a breakthrough in targeted tissue repair.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
You May Also Like
Frequently Asked Questions
Everything you need to know about ARA-290
Still have questions?
Contact our support teamStay
Informed
Receive research updates, new compound announcements, and updated Certificate of Analysis releases.
Subscribe for Updates
Enter your email to receive research and COA releases
By subscribing you agree to our Privacy Policy



